Established in 2009, Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases based upon complement i...
Lead US ophthalmology medical affairs execution for pegcetacoplan at Apellis, overseeing evidence generation, KOL engagement, training and medical review to support product strategy and launch.